| Fund ID | 805-1335106209 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Arcadia Protea Sl Investors LP | Private Equity | $205.3M |
| Sl Riviera Investors 2021 LP | Private Equity | $112.9M |
| Arcadia Packaging Investors LP | Private Equity | $91.6M |
Arcadia Therabody Investors LP reports $8,831 in gross assets, among the top 100% of private funds by size.
The stated minimum investment is $50,000.
Arcadia Therabody Investors LP is managed by Arcadia Investment Partners LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.